Immune response to mRNA-based COVID-19 booster vaccination in people living with HIV.

Jakob J Malin,Isabelle Suárez,Lena M Biehl,Philipp Schommers,Elena Knops,Veronica Di Cristanziano,Eva Heger, Eva Pflieger,Christoph Wyen, Daniel Bettin,Jan Rybniker,Gerd Fätkenheuer,Clara Lehmann

HIV medicine（2023）

引用 0|浏览22

暂无评分

摘要

People living with HIV with ≥500 CD4 cells/μL showed favourable immune responses to mRNA-based COVID-19 booster vaccination. A longer time (up to 29 weeks) since second vaccination was associated with higher serological responses, whereas choice of mRNA vaccine or concomitant influenza vaccination had no impact.

查看译文

关键词

BNT-162b2,COVID-10,Comirnaty,PLWH,Spikevax,immune response,mRNA vaccine,mRNA-1273

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要